CORC

在结果中检索

CORC

浏览/检索结果: 共14条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced non-small cell lung cancer (NSCLC): results of the phase 3 CheckMate 078 study 会议论文
作者:  Wu, Yi-Long;  Lu, Shun;  Cheng, Ying;  Zhou, Caicun;  Wang, Jie
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05
Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced non-small cell lung cancer (NSCLC): results of the phase 3 CheckMate 078 study 会议论文
CANCER RESEARCH, 2018-07-01
作者:  Wu, Yi-Long;  Lu, Shun;  Cheng, Ying;  Zhou, Caicun;  Wang, Jie
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03
An updated analysis of ICOGEN to demonstrate utility of a blood-based proteomic test to predict outcomes in EGFR TKI treated patients. 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2017-05-20
作者:  Shi, Yuankai;  Han, Xiaohong;  Zhang, Li;  Ding, Lieming;  Dupuis, Nicholas
收藏  |  浏览/下载：6/0  |  提交时间：2020/01/04
A retrospective analysis of the ICOGEN clinical trial demonstrates the utility of VeriStrat to predict outcome in an all Chinese cohort treated with EGFR TKI. 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2016-05-20
作者:  Shi, Yuankai;  Han, Xiaohong;  Zhang, Li;  Ding, Lieming;  Dupuis, Nicholas
收藏  |  浏览/下载：2/0  |  提交时间：2020/01/04
An open-label, randomized, multicenter, phase III study of S-1 and cisplatin versus docetaxel and cisplatin in patients with untreated advanced non-small-cell lung cancer. 会议论文
作者:  He, Jianxing;  Shi, Yuankai;  Chang, Jianhua;  Wang, Mengzhao;  Han, Baohui
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/19
S-1 and Cisplatin versus Docetaxel and Cisplatin in Patients with Untreated Advanced NSCLC: An Randomised, Multicenter, Phase 3 Trial 会议论文
作者:  Shi, Yuankai;  Wang, Mengzhao;  He, Jianxing;  Chang, Jianhua;  Han, Baohui
收藏  |  浏览/下载：7/0  |  提交时间：2019/12/19
An open-label, randomized, multicenter, phase III study of S-1 and cisplatin versus docetaxel and cisplatin in patients with untreated advanced non-small-cell lung cancer. 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2015-05-20
作者:  He, Jianxing;  Shi, Yuankai;  Chang, Jianhua;  Wang, Mengzhao;  Han, Baohui
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/13
Multicenter randomized double-blind controlled phase III study of hhpg-19K as prophylactic therapy in patients with advanced non-small cell lung cancer (NSCLC) receiving myelosuppressive chemotherapy 会议论文
作者:  Zhou, Caicun;  Huang, Yunchao;  An, Changshan;  Wang, Donglin;  He, Jianxing
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/02
LUX-Lung 6: A randomized, open-label, phase III study of afatinib (A) vs gemcitabine/cisplatin (GC) as first-line treatment for Asian patients (pts) with EGFR mutation-positive (EGFRM plus ) advanced adenocarcinoma of the lung 会议论文
作者:  Wu, Yi-Long;  Zhou, Caicun;  Hu, Cheng-Ping;  Feng, Jifeng;  Lu, Shun
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05
BEYOND: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTRE, PHASE III STUDY OF FIRST-LINE CARBOPLATIN/PACLITAXEL (CP) PLUS BEVACIZUMAB (BV) OR PLACEBO (PL) IN CHINESE PATIENTS WITH ADVANCED OR RECURRENT NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC) 会议论文
作者:  Zhou, Caicun;  Chen, Gongyan;  Liu, Xiaoqing;  Zhu, Yunzhong;  Lu, Shun
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/19

©版权所有 ©2017 CSpace - Powered by CSpace